SQI Diagnostics, a medtech company based in Canada, is developing the TORdx LUNG Test. The technology is intended to assist clinicians in assessing donor lungs in their suitability for transplantation. At present, clinicians typically assess donor lungs using qualitative variables, such as donor health and lung size. One of the most important factors, lung inflammation, is difficult to assess, and clinicians will often play it safe and reject an organ if there is any doubt about it.

Hybrid Application: Native-like Experience with WebView — Part 2

Paragonix Technologies, a medtech company based in Massachusetts, created the SherpaPak, an FDA organ transportation device that is intended to keep donor organs safe and viable on their journey to a transplant recipient. As the viability of a donor organ can mean life or death for the receiving patient, it makes sense to take exceptional care of it in transit.

Researchers at the RIKEN Center for Biosystems Dynamics Research in Japan have developed an AI-powered robotic system that can perform laboratory experiments in regenerative medicine, learn from the results, and perform iterative rounds of experimentation to achieve a certain goal.

Credit: Getty Images/melitas